Yi-Jin Gao, MD
Shanghai Children's Medical Center
Emerging Leaders
not ranked
Current Leaders
#2055 pts
All-Time Leaders
#30232 pts
Scored by the scientific impact (publications, citations, press) of the trials they lead, weighted by role. First trial 2002. 7 trials as lead/chair. How it works →
Trials led — by scientific impact
A Randomized Trial Using a Modified COG ABFM Regimen Backbone to Investigate Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)
Phase 3RecruitingChildren's Cancer Group, China
9
impact
A Prospective Institutional Study for the Treatment of Children With Newly Diagnosed Langerhans Cell Histiocytosis Using a Cytarabine Contained Protocol
Phase 3RecruitingShanghai Children's Medical Center
5
impact
Modified BFM (Berlin-Frankfurt-Munster)Backbone Therapy for Chinese Children or Adolescents With Newly Diagnosed Lymphoblastic Lymphoma
Phase 3ActiveChildren's Cancer Group, China
5
impact
Treatment Regimen or Children or Adolescent With Mature B-cell NHL or B-AL in China
Phase 3ActiveChildren's Cancer Group, China
4
impact
Intensive Chemotherapy Combined With Early, Adequate, and Intensive Use of Rituximab for Aggressive B-NHL in Children and Adolescents
Phase 2RecruitingChildren's Cancer Group, China
4
impact
A Phase 3 Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy Incorporating a Randomized Assessment of Sodium Thiosulfate as Otoprotection for Children With Localized Disease, and Response Adapted Therapy for Patients With Metastatic Disease
Phase 3RecruitingShanghai Children's Medical Center
4
impact
Study on Compliance, Safety and Effectivity of Vaccination for Children With Hematologic Malignancies or Solid Tumors and Their Parents
N/AUnknownChildren's Cancer Group, China
0
impact
Shanghai Epidemiology Study for Adolescents and Children with Cancer
N/ARecruitingChildren's Cancer Group, China
0
impact